Conservative interventions, such as cognitive behavioral therapy and intradermal acupuncture, may improve the sleep of adults with a history of stroke or traumatic brain injury.
Study researchers investigated whether the COVID-19 pandemic potentially contributed to the delay in acute stroke care.
A Mobile Interventional Stroke Team (MIST) resulted in improved clinical outcomes for emergent large vessel occlusion (ELVO) stroke.
Study researchers compared patients treated after 6 hours with those treated within 6 hours after symptom onset, and with clinical endpoints of the DAWN and DEFUSE 3 trials.
Only about two-thirds of adults in the United States could identify the combination of recommended stroke knowledge, suggesting more education and outreach is needed.
COVID-19 as a cause of increased risk of stroke was assessed by research authors, who compiled discharge data from electronic medical records from 6 stroke facilities in New York.
Circulating metabolites, including amino acids, glycolysis-related metabolites, acute phase reaction markers, and lipoprotein subfractions, are associated with the risk for stroke.
Edoxaban was found to be superior to placebo for the prevention of stroke and systemic embolism in very elderly Japanese patients with nonvalvular atrial fibrillation.
Increasing severity of white matter lesions are predictive of poor functional outcomes following acute ischemic stroke, but do not alter the effect of EVT.
Repeated remote ischemic post-conditioning combined with intravenous thrombolysis can promote nerve function recovery and improve prognosis after acute ischemic stroke.